Status:
COMPLETED
Breaking Potentially Bad News in Lung Cancer Workup: Telephone Versus In-person Breaking of Final Diagnosis
Lead Sponsor:
Naestved Hospital
Collaborating Sponsors:
University of Copenhagen
Conditions:
Lung Cancer
Diagnoses Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Disclosure of bad news is challenging for patients, relatives and healthcare providers. Current protocols for breaking bad news assume a single, in-person meeting for breaking bad news, however cancer...
Detailed Description
Lung cancer is the most common cause of cancer death worldwide. Patient-friendly delivery of results of lung cancer workup is mandatory in an era of personalized medicine. The possibility of deliverin...
Eligibility Criteria
Inclusion
- (all are mandatory)
- suspicions lesions in lung, chest wall or mediastinum at CT or PET-CT
- a clinician's decision of invasive work-up for suspected or possible malignancy.
- expected survival of more than 5 weeks (as judged by a local investigator).
Exclusion
- age younger than 18 years
- need of in-patient care
- disease manifestation needing urgent care (e.g. spinal cord compression, superior vena cava superior syndrome) and
- inability to provide verbal and written informed consent -
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2019
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04315207
Start Date
October 1 2012
End Date
September 15 2019
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Respiratory Medicine
Næstved, Denmark, DK-4700